相关实验视频

Updated: May 9, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

梅特福林的使用和乳腺癌相关淋巴的风险:回顾性分析

Jonathan Rubin¹, Bracha Pollack¹, Janet Coleman-Belin¹

¹Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Journal of the American College of Surgeons

|May 5, 2025

概括

甲福明可能会降低患有糖尿病的乳腺癌患者的淋巴风险. 这项研究发现,使用甲福明的糖尿病患者接受了下淋巴结解剖 (ALND),淋巴结的发病率较低.

科学领域:

在瘤学瘤学.
内分泌学在内分泌学.
淋巴 edem 研究研究淋巴 edem 研究

背景情况:

淋巴 edem 影响超过30%的乳腺癌患者后状淋巴结解剖 (ALND).
糖尿病 (DM) 可能会加剧因内皮功能障碍引起的淋巴风险.
甲胺是一种DM药物,在减少淋巴方面显示出临床前有前途的承诺.

研究的目的:

调查甲福明使用与糖尿病乳腺癌患者淋巴风险之间的关联.
分析ALND糖尿病患者的淋巴 edem 发病率,通过甲福明治疗分层.

主要方法:

追溯分析4,882名接受ALND (2004-2022) 的乳腺癌患者.
基于手术时使用甲福明的糖尿病患者的分层.
单变量和多变量分析以评估风险因素和治疗效应.

主要成果:

在ALND发生时,糖尿病是淋巴的重要危险因素 (多变量HR:1.55).
糖尿病患者的甲福明治疗与淋巴瘤风险显著降低有关 (多变量HR:0.62).
在407名糖尿病患者中,有250人服用甲福林,淋巴 edem 的发病率较低.

结论:

糖尿病乳腺癌患者在ALND后面临更高的淋巴风险.
在ALND时使用甲胺与糖尿病患者淋巴的发病率降低有关.

更多相关视频

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Published on: January 12, 2017

相关概念视频

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...